We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
26
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$546M 0.55%
12,713,868
+1,129,173
+10% +$54.1M
XLK icon
27
State Street Technology Select Sector SPDR ETF
XLK
$123B
$533M 0.54%
8,969,664
+270,572
+3% +$18.5M
ABBV icon
28
AbbVie
ABBV
$435B
$532M 0.54%
3,964,259
+170,536
+4% +$24.5M
CSCO icon
29
Cisco
CSCO
$479B
$527M 0.53%
13,163,717
-142,517
-1% -$6.32M
WMT icon
30
Walmart Inc
WMT
$890B
$526M 0.53%
12,156,258
+231,891
+2% +$10.2M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.32T
$521M 0.53%
5,418,266
-172,394
-3% -$19.3M
IWD icon
32
iShares Russell 1000 Value ETF
IWD
$83.9B
$505M 0.51%
3,714,507
-283,410
-7% -$42.6M
IVV icon
33
iShares Core S&P 500 ETF
IVV
$904B
$476M 0.48%
1,328,560
+141,371
+12% +$56.5M
ETN icon
34
Eaton
ETN
$174B
$463M 0.47%
3,475,317
+65,606
+2% +$9.18M
CB icon
35
Chubb
CB
$135B
$448M 0.45%
2,461,465
+86,166
+4% +$16.4M
CVX icon
36
Chevron
CVX
$366B
$444M 0.45%
3,093,029
+73,949
+2% +$11.3M
CME icon
37
CME Group
CME
$94.8B
$444M 0.45%
2,508,723
+51,405
+2% +$10.2M
MSI icon
38
Motorola Solutions
MSI
$77.4B
$434M 0.44%
1,935,994
+39,160
+2% +$9.24M
CMCSA icon
39
Comcast
CMCSA
$90B
$433M 0.44%
14,763,798
-411,093
-3% -$15.4M
DVN icon
40
Devon Energy
DVN
$47.3B
$428M 0.43%
7,114,606
+380,663
+6% +$23.7M
UPS icon
41
United Parcel Service
UPS
$88.9B
$406M 0.41%
2,512,339
-37,743
-1% -$7.15M
MPC icon
42
Marathon Petroleum
MPC
$83.7B
$396M 0.4%
3,987,374
+86,231
+2% +$8.07M
APD icon
43
Air Products & Chemicals
APD
$67.6B
$393M 0.4%
1,690,063
+45,446
+3% +$11.3M
VYM icon
44
Vanguard High Dividend Yield ETF
VYM
$83.5B
$374M 0.38%
3,940,880
+8,419
+0.2% +$876K
PG icon
45
Procter & Gamble
PG
$339B
$364M 0.37%
2,883,583
+143,744
+5% +$20.4M
COST icon
46
Costco
COST
$420B
$363M 0.37%
769,368
+4,612
+0.6% +$2.4M
USHY icon
47
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
$360M 0.36%
10,711,512
-2,164,317
-17% -$77M
NVDA icon
48
NVIDIA
NVDA
$5.42T
$360M 0.36%
29,646,830
-352,730
-1% -$5.58M
PFE icon
49
Pfizer
PFE
$153B
$359M 0.36%
8,194,115
+164,241
+2% +$7.98M
MTUM icon
50
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$354M 0.36%
2,700,556
+122,257
+5% +$17.1M

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.